Cargando…
Experimental amyloidosis: the inducer is a polyclonal B-cell activator to which susceptibility is under genetic control
Experimental amyloidosis in mice can be induced by repeated injections of casein. It has now been demonstrated that casein induces strong polyclonal antibody synthesis in mouse B spleen lymphocytes. This effect is much more pronounced in spleen cells from anyloid-susceptible mice (CBA/J) than amyloi...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1975
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190064/ https://www.ncbi.nlm.nih.gov/pubmed/1104749 |
_version_ | 1782146743483236352 |
---|---|
collection | PubMed |
description | Experimental amyloidosis in mice can be induced by repeated injections of casein. It has now been demonstrated that casein induces strong polyclonal antibody synthesis in mouse B spleen lymphocytes. This effect is much more pronounced in spleen cells from anyloid-susceptible mice (CBA/J) than amyloid-resistant mice (A/J). It is suggested that amyloidosis can be due in some instances to a constant exposure for molecules which induce polyclonal B-cell activation. |
format | Text |
id | pubmed-2190064 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1975 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21900642008-04-17 Experimental amyloidosis: the inducer is a polyclonal B-cell activator to which susceptibility is under genetic control J Exp Med Articles Experimental amyloidosis in mice can be induced by repeated injections of casein. It has now been demonstrated that casein induces strong polyclonal antibody synthesis in mouse B spleen lymphocytes. This effect is much more pronounced in spleen cells from anyloid-susceptible mice (CBA/J) than amyloid-resistant mice (A/J). It is suggested that amyloidosis can be due in some instances to a constant exposure for molecules which induce polyclonal B-cell activation. The Rockefeller University Press 1975-12-01 /pmc/articles/PMC2190064/ /pubmed/1104749 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Articles Experimental amyloidosis: the inducer is a polyclonal B-cell activator to which susceptibility is under genetic control |
title | Experimental amyloidosis: the inducer is a polyclonal B-cell activator to which susceptibility is under genetic control |
title_full | Experimental amyloidosis: the inducer is a polyclonal B-cell activator to which susceptibility is under genetic control |
title_fullStr | Experimental amyloidosis: the inducer is a polyclonal B-cell activator to which susceptibility is under genetic control |
title_full_unstemmed | Experimental amyloidosis: the inducer is a polyclonal B-cell activator to which susceptibility is under genetic control |
title_short | Experimental amyloidosis: the inducer is a polyclonal B-cell activator to which susceptibility is under genetic control |
title_sort | experimental amyloidosis: the inducer is a polyclonal b-cell activator to which susceptibility is under genetic control |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190064/ https://www.ncbi.nlm.nih.gov/pubmed/1104749 |